David J Uhlinger

Title: The Innovations of David J Uhlinger

Introduction

David J Uhlinger is an accomplished inventor based in Flemington, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of diagnostic applications. His work has implications for drug discovery and detection assays, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

David J Uhlinger holds a patent for a diagnostic application related to a novel molecule known as MAIL (Molecule possessing Ankyrin repeats Induced by LPS). This invention provides nucleic acids, polypeptides, antibodies, and cells that are expressed in LPS-stimulated monocytes. The isolated components can be utilized in various detection assays, screening methods, and drug discovery assays. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Uhlinger is currently associated with Janssen Pharmaceutica NV, a company known for its commitment to research and development in pharmaceuticals. His role at the company allows him to work on cutting-edge projects that aim to improve healthcare outcomes. His expertise in biotechnology has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, David has collaborated with notable professionals, including George Ho and Michael R D'Andrea. These collaborations have likely enriched his work and contributed to the success of his projects.

Conclusion

David J Uhlinger exemplifies the spirit of innovation in biotechnology through his patent and work at Janssen Pharmaceutica NV. His contributions to diagnostic applications highlight the importance of research in advancing medical science.